Compares imaging scans for finding tumors in children and young adults
Compares MR, PET/MR and PET/CT scans for diagnosing tumors in young people.
Key facts
- Who runs it
- Stanford University
- Where
- Palo Alto, United StatesSee the site
- Trial code
- Registry title
- Pediatric PET/MR Image Registry
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 1 Feb 2018
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Treatments tested
- PET/MR imaging
- MR imaging
- PET/CT imaging
- Record updated
- 9 February 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and young adults with a proven solid tumor or a new mass strongly suspected to be a solid tumor. It compares different scans for diagnosing tumors.
- Age
- Up to 40 years.
- Sex
- Males and females can join.
- Disease stage
- Proven solid tumors, or a newly found mass strongly suspected to be a solid tumor. Some patients with leukemia may join if a focal lesion in an organ is a concern.
Main reasons for not taking part
- Cannot have an MRI or PET/MR scan, for example a cardiac pacemaker or intracranial vascular clips
- Blood glucose level above 200 mg/dl (11.1 mmol/L)
- Primary tumor of the central nervous system (CNS)
- Pregnant women
- No informed consent (or parental permission if under 18)
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor
- We might also include some patients with leukemia if there is concern for a focal lesion in any of their organs
- Participant's parents (if participant is under 18) or the participant (if participant is 18 years or older) must willingly give written informed consent prior to any image transfer to the image registry
Who cannot take part
- Patient has contraindications for MRI or PET/MR. This includes patients with cardiac pacemakers or intracranial vascular clips as well as patients with a blood glucose level > 200 mg/dl
- Lack of parental permission (if participant is younger than 18) or lack of informed consent (if participant is at least 18 years of age)
- Patient has a CNS primary tumor
- Pregnant women and fetuses
Where in United States
- Stanford University, School of MedicinePalo Alto, United StatesContact: Anne MueheTaking people
About the trial
What the trial wants to find out
The purpose of this study is to compare whole body magnetic resonance (MR) imaging, whole body positron emission tomography (PET)/MR imaging, and (if available) PET/Computed Tomography (CT) imaging for the diagnosis of tumors in children and young adults. Sensitivities, specificities and diagnostic accuracies of the different imaging modalities will be compared for significant differences.
The group in the trial
- Image Registry
patients with proven solid tumors or newly diagnosed mass strongly suspected to represent a solid tumor will receive MR imaging, PET/MR imaging (and if available, PET/CT imaging)
Treatment: PET/MR imaging, MR imaging, and PET/CT imaging
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pediatric PET/MR Image Registry
- Plain-language title
- Compares imaging scans for finding tumors in children and young adultsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 9 February 2026